Keyphrases
Spain
100%
Catalonia
47%
Confidence Interval
39%
Barcelona
38%
G Protein-coupled Receptor
25%
Randomized Controlled Trial
20%
Risk Factors
19%
Odds Ratio
19%
Tumor
18%
Endometrial Cancer
18%
Meta-analysis
17%
High Risk
17%
Pediatric
16%
COVID-19
16%
Pregnant Women
14%
HIV Patients
14%
Pediatric Patients
13%
AIDS/HIV
13%
Preeclampsia
13%
Systematic Meta-analysis
12%
Body Mass Index
12%
Europe
11%
Fetus
11%
Quality of Life
11%
Donor-acceptor
10%
During Pregnancy
10%
Adverse Events
10%
Randomized Clinical Trial
10%
Breast Cancer
10%
Copyright
9%
Primary Care
9%
Placebo
9%
Hazard Ratio
9%
Clinical Trials
8%
Gestational Age
8%
Neuroblastoma
8%
Chemotherapy
8%
Familial Pancreatic Cancer
8%
Clinical Practice
8%
Hospitalization
8%
D Study
8%
Multivariate Analysis
8%
Cardiovascular Risk
8%
Clinical Outcomes
8%
University Hospital
8%
Obesity
8%
Epidemiology
7%
Myocardial Infarction
7%
Pancreatic Cancer
7%
HIV-positive
7%
Prognostic Factors
7%
Clinical Characteristics
7%
Multiple Sclerosis
7%
KRAS mutation
7%
Rhodopsin
7%
Type 1 Diabetes Mellitus (T1DM)
7%
Overall Survival
7%
Sexually Transmitted Infections
7%
Highly Active Antiretroviral Therapy (HAART)
7%
Clinical Practice Guidelines
7%
Quantitative PCR
7%
Emergency Department
7%
Vaccination
6%
Alzheimer's Disease
6%
Antiretroviral Therapy
6%
Comorbidity
6%
Diabetes
6%
Persistent Organic Pollutants
6%
MEDLINE
6%
Hepatocellular Carcinoma
6%
Men Who Have Sex with Men
6%
Endometrial Carcinoma
6%
No Significant Difference
6%
Polymorphism
6%
Asthma
6%
HIV Infection
6%
Gestational Diabetes Mellitus
6%
Healthcare Workers
6%
Early Diagnosis
6%
Lipids
6%
Cardiovascular Disease
6%
Rhabdomyosarcoma
6%
Genotype
6%
Perinatal Outcome
5%
Hepatitis C Virus
5%
Molecular Dynamics Simulation
5%
Prospective Cohort Study
5%
Age Groups
5%
Placental Growth Factor (PlGF)
5%
Human Immunodeficiency Virus Type 1 (HIV-1)
5%
High Prevalence
5%
Helix
5%
High-risk Human Papillomavirus (HR-HPV)
5%
Growth Hormone
5%
Health-related Quality of Life
5%
Cocaine
5%
Incidence Rate
5%
Older Adults
5%
Receptor Activation
5%
Tertiary Hospital
5%
Medicine and Dentistry
Diseases
46%
Human Immunodeficiency Virus
40%
Neoplasm
32%
Pediatrics
31%
Systematic Review
29%
Infection
25%
Malignant Neoplasm
22%
Prevalence
22%
Uterine Cancer
20%
Randomized Controlled Trial
18%
Breast Cancer
17%
Meta-Analysis
17%
Biological Marker
16%
Diagnosis
16%
Observational Study
15%
Adolescence
13%
Quality of Life
13%
Cohort Analysis
13%
Odds Ratio
13%
COVID-19
13%
Neonatal Infant
12%
Adverse Event
12%
Pre-Eclampsia
12%
Health Care Cost
11%
Clinical Trial
11%
Recurrent Disease
11%
Pregnancy
10%
Surgery
10%
Primary Health Care
10%
Screening
10%
Body Mass Index
10%
Pediatrics Patient
9%
Cross Sectional Study
9%
Premature Labor
9%
Cervical Cancer
9%
Obstetrics
9%
Chemotherapy
9%
Prospective Study
9%
Endometrium Carcinoma
8%
Cohort Effect
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Metastatic Carcinoma
8%
Apoplexy
8%
Overall Survival
8%
Placebo
8%
Gestational Age
8%
Randomized Clinical Trial
8%
Health Care
8%
Diabetes
8%
Hazard Ratio
7%
Hepatocellular Carcinoma
7%
Gestational Diabetes
7%
Ganglioneuroblastoma
7%
Bleeding
7%
Liver Cirrhosis
7%
Ovarian Cancer
7%
Prognostic Factor
6%
Receptor
6%
Lung
6%
Magnetic Resonance Imaging
6%
Cardiovascular Disease
6%
Retroperitoneal Lymph Node Dissection
6%
Logistic Regression Analysis
6%
Retrospective Study
6%
Prospective Cohort Study
6%
Emergency Department
6%
Cancer
6%
Antiretroviral Therapy
6%
Population
5%
Intensive Care Unit
5%
Exocrine Pancreatic Cancer
5%
Pessary
5%
Placental Growth Factor
5%
First Trimester Pregnancy
5%
Multiple Sclerosis
5%
Comorbidity
5%
Wart Virus
5%
Rhabdomyosarcoma
5%
Growth Hormone
5%
Pancreas Cancer
5%
Human Immunodeficiency Virus Infection
5%
Diabetes Mellitus
5%
Men Who Have Sex with Men
5%
Hepatitis C Virus
5%
Cervix
5%
Multivariate Analysis
5%
Case-Control Study
5%
In Vitro
5%